Related Experiment Video
Updated: Mar 14, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Bulking up the hippocampus in schizophrenia: a role for 5-HT1A agonists?
1, MD, PhD, FRCPsych, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Summary:
The volume of the hippocampus is reduced in patients with schizophrenia, and this deficit tends to become more pronounced with chronicity. Newer antipsychotics may protect against the progressive reductions in hippocampal volume while preliminary data offer hope that specific antipsychotics may act to reverse it.
Declaration Of Interest:
None.
Copyright And Usage:
© The Royal College of Psychiatrists 2016. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) licence.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Antidepressant Drugs: MAOIs and Other Agents
Role of Hippocampus in Memory
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Antipsychotic Drugs: Typical and Atypical Agents
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

